On the basis of IFN-γ as one target of miR-29 [15], it has been suggested that up-regulated miR-29 in CD4+ T cells might in turn inhibit IFN-γ mRNA expression in both the LTBI and active TB group. This evidence concerns the gene CD4 and tuberculosis.